These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25394491)

  • 21. Neurocognitive performance of a community-based sample of young people at putative ultra high risk for psychosis: support for the processing speed hypothesis.
    Kelleher I; Murtagh A; Clarke MC; Murphy J; Rawdon C; Cannon M
    Cogn Neuropsychiatry; 2013; 18(1-2):9-25. PubMed ID: 22991935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying youth at risk for psychosis using the Behavior Assessment System for Children, Second Edition.
    Thompson E; Kline E; Reeves G; Pitts SC; Schiffman J
    Schizophr Res; 2013 Dec; 151(1-3):238-44. PubMed ID: 24119463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report.
    Carandang CG; Scholten MC
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):115-20. PubMed ID: 17343559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The social brain network in 22q11.2 deletion syndrome: a diffusion tensor imaging study.
    Olszewski AK; Kikinis Z; Gonzalez CS; Coman IL; Makris N; Gong X; Rathi Y; Zhu A; Antshel KM; Fremont W; Kubicki MR; Bouix S; Shenton ME; Kates WR
    Behav Brain Funct; 2017 Feb; 13(1):4. PubMed ID: 28209179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emotional and behavioral symptomatology reported by help-seeking youth at clinical high-risk for psychosis.
    Thompson E; Kline E; Ellman LM; Mittal V; Reeves GM; Schiffman J
    Schizophr Res; 2015 Mar; 162(1-3):79-85. PubMed ID: 25638728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome.
    Ramanathan S; Mattiaccio LM; Coman IL; Botti JC; Fremont W; Faraone SV; Antshel KM; Kates WR
    Schizophr Res; 2017 Oct; 188():35-41. PubMed ID: 27988073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping cortical morphology in youth with velocardiofacial (22q11.2 deletion) syndrome.
    Kates WR; Bansal R; Fremont W; Antshel KM; Hao X; Higgins AM; Liu J; Shprintzen RJ; Peterson BS
    J Am Acad Child Adolesc Psychiatry; 2011 Mar; 50(3):272-282.e2. PubMed ID: 21334567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome.
    Schneider M; Armando M; Schultze-Lutter F; Pontillo M; Vicari S; Debbané M; Eliez S
    Schizophr Res; 2019 Apr; 206():386-393. PubMed ID: 30414720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome.
    Hooper SR; Curtiss K; Schoch K; Keshavan MS; Allen A; Shashi V
    Res Dev Disabil; 2013 May; 34(5):1758-69. PubMed ID: 23506790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neural correlates of non-spatial working memory in velocardiofacial syndrome (22q11.2 deletion syndrome).
    Kates WR; Krauss BR; Abdulsabur N; Colgan D; Antshel KM; Higgins AM; Shprintzen RJ
    Neuropsychologia; 2007 Sep; 45(12):2863-73. PubMed ID: 17618656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inter-rater reliability of subthreshold psychotic symptoms in individuals with 22q11.2 deletion syndrome.
    Moore TM; Salzer D; Bearden CE; Calkins ME; Kates WR; Kushan L; Gallagher RS; Frumer DS; Weinberger R; McDonald-McGinn DM; Gur RE; Gothelf D
    J Neurodev Disord; 2021 Jun; 13(1):23. PubMed ID: 34126928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical gyrification in velo-cardio-facial (22q11.2 deletion) syndrome: a longitudinal study.
    Kunwar A; Ramanathan S; Nelson J; Antshel KM; Fremont W; Higgins AM; Shprintzen RJ; Kates WR
    Schizophr Res; 2012 May; 137(1-3):20-5. PubMed ID: 22365148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early prodromal symptoms can predict future psychosis in familial high-risk youth.
    Tandon N; Montrose D; Shah J; Rajarethinam RP; Diwadkar VA; Keshavan MS
    J Psychiatr Res; 2012 Jan; 46(1):105-10. PubMed ID: 22056319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
    Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
    J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome).
    Jolin EM; Weller RA; Weller EB
    Curr Psychiatry Rep; 2009 Apr; 11(2):99-105. PubMed ID: 19302762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neuropsychological phenotype of velocardiofacial syndrome (VCFS): relationship to psychopathology.
    Lajiness-O'Neill R; Beaulieu I; Asamoah A; Titus JB; Bawle E; Ahmad S; Kirk JW; Pollack R
    Arch Clin Neuropsychol; 2006 Feb; 21(2):175-84. PubMed ID: 16307864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annotation: velo-cardio-facial syndrome.
    Murphy KC
    J Child Psychol Psychiatry; 2005 Jun; 46(6):563-71. PubMed ID: 15877762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications.
    Mekori-Domachevsky E; Taler M; Weinberger R; Guri Y; Dar S; Shani S; Dekel I; Weizman A; Gothelf D
    Schizophr Res; 2021 May; 231():164-169. PubMed ID: 33866261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.